Selenoracil derivatives are potent inhibitors of the selenoenzyme type I iodothyronine deiodinase
- 30 December 1992
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 189 (3), 1362-1367
- https://doi.org/10.1016/0006-291x(92)90224-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Type I iodothyronine deiodinase is a selenocysteine-containing enzymeNature, 1991
- Identification of type I iodothyronine 5′-deiodinase as a selenoenzymeBiochemical and Biophysical Research Communications, 1990
- Mass spectral studies of 6‐n‐propyl‐2‐thiouracil, its oxygen, selenium and fluorinated congeners∗Toxicological & Environmental Chemistry, 1990
- Inhibition of type I and type II iodothyronine deiodinase activity in rat liver, kidney and brain produced by selenium deficiencyBiochemical Journal, 1989
- Antithyroid DrugsThe New England Journal of Medicine, 1984
- Modification of rat liver iodothyronine 5′-deiodinase activity with diethylpyrocarbonate and Rose Bengal; Evidence for an active site histidine residueBiochemical and Biophysical Research Communications, 1984
- Characterization of Essential Enzyme Sulfhydryl Groups of Thyroxine 5′-Deiodinase from Rat Kidney*Endocrinology, 1980
- Mechanism of action of iodothyronine-5′-deiodinaseBiochimica et Biophysica Acta (BBA) - Enzymology, 1979
- Inhibition of iodothyronine 5′-deiodinase by thioureylenes; Structure-activity relationshipFEBS Letters, 1979
- Thyroxine 5?-Deiodinase Activity of Rat Kidney: Observations on Activation by Thiols and Inhibition by Propylthiouracil*Endocrinology, 1978